Health Care & Life Sciences » Pharmaceuticals | China Grand Pharmaceutical & Healthcare Holdings Ltd.

China Grand Pharmaceutical & Healthcare Holdings Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,658
3,122
3,246
3,696
4,771
5,958
Cost of Goods Sold (COGS) incl. D&A
1,773
1,941
1,907
1,976
2,304
2,813
Gross Income
885
1,181
1,338
1,720
2,466
3,145
SG&A Expense
611
945
1,057
1,282
1,827
2,317
EBIT
281
249
287
442
640
828
Unusual Expense
159
27
16
19
39
13
Non Operating Income/Expense
80
79
86
63
18
164
Interest Expense
78
114
157
182
174
203
Pretax Income
132
203
241
314
559
884
Income Tax
27
27
40
45
73
147
Equity in Affiliates
-
-
-
-
-
-
Consolidated Net Income
105
176
200
269
486
736
Net Income
100
175
181
269
461
713
Net Income After Extraordinaries
100
175
181
269
461
713
Net Income Available to Common
100
175
181
269
461
713
EPS (Basic)
0.05
0.09
0.09
0.13
0.20
0.28
Basic Shares Outstanding
1,973
1,973
1,973
2,073
2,249
2,569
EPS (Diluted)
0.05
0.09
0.09
0.12
0.19
0.27
Diluted Shares Outstanding
1,973
2,024
2,219
2,318
2,495
2,791
EBITDA
388
427
478
662
883
1,065
Other Operating Expense
7
13
5
5
-
-
Non-Operating Interest Income
8
15
15
12
4
12
Minority Interest Expense
-
6
1
20
25
24
Equity in Affiliates (Pretax)
-
1
6
3
2
69

About China Grand Pharmaceutical & Healthcare Holdings

View Profile
Address
Units 3302, 33/F
Hong Kong
Hong Kong
Employees -
Website http://www.chinagrandpharm.com
Updated 07/08/2019